Zhang N, Shao X, Xu L, Zhu W, Wang H, Luo R
BMC Cancer. 2025; 25(1):465.
PMID: 40082810
PMC: 11907953.
DOI: 10.1186/s12885-025-13879-6.
Kaur R, Sharma A, Wijekoon N
EXCLI J. 2025; 24:267-285.
PMID: 40071025
PMC: 11895054.
DOI: 10.17179/excli2024-7973.
Huang G, Xu G, Cao Q, Li S, Li H, Zhang X
NPJ Precis Oncol. 2025; 9(1):64.
PMID: 40055530
PMC: 11889224.
DOI: 10.1038/s41698-025-00833-9.
Zhu X, Li P, Qu H, Ai X, Zhao Z, He J
Hum Cell. 2025; 38(3):65.
PMID: 40053279
DOI: 10.1007/s13577-025-01197-9.
Xu X, Han Y, Song Y, Zhou Z, Chen S, Liu Y
Oncol Lett. 2025; 29(4):196.
PMID: 40046638
PMC: 11880884.
DOI: 10.3892/ol.2025.14942.
Axillary lymph node metastasis in breast cancer: from historical axillary surgery to updated advances in the preoperative diagnosis and axillary management.
Wu T, Long Q, Zeng L, Zhu J, Gao H, Deng Y
BMC Surg. 2025; 25(1):81.
PMID: 40016717
PMC: 11869450.
DOI: 10.1186/s12893-025-02802-2.
Manufacturing and Financial Evaluation of Peptide-Based Neoantigen Cancer Vaccines for Triple-Negative Breast Cancer in the United Kingdom: Opportunities and Challenges.
Novakova A, Morris S, Vaiarelli L, Frank S
Vaccines (Basel). 2025; 13(2).
PMID: 40006691
PMC: 11860436.
DOI: 10.3390/vaccines13020144.
The Role of the Fox Gene in Breast Cancer Progression.
Pei S, Zhang D, Li Z, Liu J, Li Z, Chen J
Int J Mol Sci. 2025; 26(4).
PMID: 40003882
PMC: 11855465.
DOI: 10.3390/ijms26041415.
Modulation of Wnt/Beta-Catenin Pathway by Major Dietary Phytochemicals Against Breast Cancer Development.
Lieb N, Tran A, Torres M, Bommareddy A
Biology (Basel). 2025; 14(2).
PMID: 40001961
PMC: 11851881.
DOI: 10.3390/biology14020194.
Propofol reduces breast cancer cell stemness via FOXO3/SOX2 axis.
Fang W, Zhang X, Yu Y, Ge J, Meng R
J Cancer. 2025; 16(5):1555-1562.
PMID: 39991565
PMC: 11843230.
DOI: 10.7150/jca.104142.
Study the Expression of Two Circular RNAs, hsa_circ_0003227 and hsa_circ_0001666, in the Primary Breast Cancer Cell Line BT-20 and the Metastatic Breast Cancer Cell Line MCF-7.
Absalan S, Vaziri H, Hadavi M
Biochem Genet. 2025; .
PMID: 39976889
DOI: 10.1007/s10528-025-11051-0.
Oxidative phosphorylation-related genes for prognosis and tumor microenvironment in breast cancer.
Xia M, Dong S, Wang C
Transl Cancer Res. 2025; 14(1):497-511.
PMID: 39974386
PMC: 11833400.
DOI: 10.21037/tcr-24-1181.
Development and validation of a functional ex vivo paclitaxel and eribulin sensitivity assay for breast cancer, the REMIT assay.
Komar Z, Verkaik N, Dahmani A, Montaudon E, Kanaar R, Houtsmuller A
NPJ Breast Cancer. 2025; 11(1):17.
PMID: 39962055
PMC: 11832732.
DOI: 10.1038/s41523-025-00734-x.
Identifying traditional Chinese medicine combinations for breast cancer treatment based on transcriptional regulation and chemical structure.
Li S, Zhang L, Zhang W, Chen H, Hong M, Xia J
Chin Med. 2025; 20(1):23.
PMID: 39953557
PMC: 11829537.
DOI: 10.1186/s13020-025-01074-5.
Investigating the role of cathepsins in breast cancer progression: a Mendelian randomization study.
Zhou S, Sun Y, Zha W, Zhou G
Front Oncol. 2025; 15:1408723.
PMID: 39944834
PMC: 11815281.
DOI: 10.3389/fonc.2025.1408723.
Current Evidence on the Impact of Diet, Food, and Supplement Intake on Breast Cancer Health Outcomes in Patients Undergoing Endocrine Therapy.
Zuza Prastalo M, Pokimica B, Arsic A, Ilich J, Vucic V
Nutrients. 2025; 17(3).
PMID: 39940314
PMC: 11820974.
DOI: 10.3390/nu17030456.
Cutaneous metastases of invasive lobular breast cancer as the first clinical manifestation: a case report.
Karaja S, Almohamed A, Qatza A, Aldolly A, Mansour S, Almasri A
J Int Med Res. 2025; 53(2):3000605251314804.
PMID: 39917848
PMC: 11806458.
DOI: 10.1177/03000605251314804.
Machine learning identifies the association between second primary malignancies and postoperative radiotherapy in young-onset breast cancer patients.
Lai Y, Huang P
PLoS One. 2025; 20(2):e0316722.
PMID: 39913454
PMC: 11801551.
DOI: 10.1371/journal.pone.0316722.
Decoding mutational signatures in breast cancer: Insights from a multi-cohort study.
Betz M, Witz A, Dardare J, Michel C, Massard V, Boidot R
Transl Oncol. 2025; 53:102315.
PMID: 39908964
PMC: 11847527.
DOI: 10.1016/j.tranon.2025.102315.
MicroRNA‑96 promotes the proliferation and migration of breast cancer cells by inhibiting Smad7 expression.
Zhang X, Cong L, Yu R, Yu Q, Hou X, Zhou Y
Oncol Lett. 2025; 29(3):151.
PMID: 39898288
PMC: 11783994.
DOI: 10.3892/ol.2025.14897.